Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
BND ETF Falls 0.2%

BND ETF Falls 0.2%

Dow JonesDow Jones2026/08/17 20:35

This article was automatically generated using Dow Jones technology.

Shares of Vanguard Total Bond Market ETF shed 0.2% to $72.16 Monday on what proved to be an overall poor trading session for the U.S. stock market, with the S&P 500 Index falling 0.5% to 7,745.06.

This was the fund's second consecutive day of losses.

The ETF's shares closed 4.1% below the 52-week high of $75.23 seen on February 27, 2026.

Trading volume was 7,744,864, compared to the 65-day average trading volume of 8,262,211.

As of August 14, the fund's net asset value totaled $72.28 per share.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 17, 2026 16:35 ET (20:35 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Twice thwarted in a week! Novartis (NVS.US) fails in phase III trial for blockbuster heart disease drug, stock plummets; Amgen (AMGN.US) dragged down as well

Swiss pharmaceutical giant Novartis has suffered another clinical trial setback—within one week, the company’s second major drug candidate has failed in a late-stage study. This latest disappointment concerns its potential blockbuster heart disease drug pelacarsen.

智通财经2026/09/07 07:31
Twice thwarted in a week! Novartis (NVS.US) fails in phase III trial for blockbuster heart disease drug, stock plummets; Amgen (AMGN.US) dragged down as well